Print Page   |   Contact Us   |   Report Abuse   |   Sign In   |   Join
News & Press: General

FDA Drug Safety Communication

Tuesday, September 26, 2017   (0 Comments)
Posted by: Judy Pfeiffer
Share |

 

FDA Drug Safety Communication: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks. This provides updated information to the FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning issued on August 31, 2016.

 

To learn more click here: https://www.fda.gov/Drugs/DrugSafety/ucm575307.htm


Membership Software Powered by YourMembership  ::  Legal